Long-term remission after surgical excision and minimal rituximab exposure in localized high-grade B-cell lymphoma with 11q aberration
Journal of Clinical and Experimental Hematopathology · 2026
DOI: 10.3960/jslrt.26047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Shoki Yamada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Fukushima Medical University, Fukushima, Fukushima, Japan. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Fukushima Medical University, Fukushima, Fukushima, Japan.
- Department of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan.
Zitieren
APA
Yamada, S., Koyama, D., Takeda, M., & Hashimoto, Y. (2026). Long-term remission after surgical excision and minimal rituximab exposure in localized high-grade B-cell lymphoma with 11q aberration. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.26047
Vancouver
Yamada S, Koyama D, Takeda M, Hashimoto Y. Long-term remission after surgical excision and minimal rituximab exposure in localized high-grade B-cell lymphoma with 11q aberration. Journal of Clinical and Experimental Hematopathology. 2026. doi:10.3960/jslrt.26047
BibTeX
@article{Yamada2026,
author = {Yamada, Shoki and Koyama, Daisuke and Takeda, Moe and Hashimoto, Yuko},
title = {Long-term remission after surgical excision and minimal rituximab exposure in localized high-grade B-cell lymphoma with 11q aberration},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2026},
doi = {10.3960/jslrt.26047}
}
EUVIMED